Latest News

Roche Holding (SWX:ROG) reported positive Phase III MAJESTY trial results for Gazyva in primary membranous nephropathy. The company announced Gazyva as a potential first in class option for this rare kidney disease with limited treatment choices. Roche appointed Mark Dawson as the new Head of Pharma Research and Early Development. For you as an investor, these updates sit against a backdrop where Roche Holding shares trade at CHF369.2, with the stock up 5.2% over the past week, 5.8% over 30...

The United Kingdom's market has recently faced challenges, with the FTSE 100 index closing lower due to weak trade data from China, highlighting global economic interconnectedness. In such a fluctuating environment, investors often seek stocks that combine affordability with potential growth. While the term "penny stocks" might seem outdated, these smaller or newer companies continue to offer intriguing opportunities for those looking for value and potential upside in their investment...

The market shrugged off Biohit Oyj's ( HEL:BIOBV ) solid earnings report. Our analysis showed that there are some...

The most recent earnings report from NoHo Partners Oyj ( HEL:NOHO ) was disappointing for shareholders. However, our...

The analysts covering G5 Entertainment AB (publ) ( STO:G5EN ) delivered a dose of negativity to shareholders today, by...

In late December 2025, Corcept Therapeutics received a Complete Response Letter from the U.S. FDA for its relacorilant NDA in hypertension secondary to hypercortisolism, with the agency requesting additional evidence of effectiveness and expressing concerns about the clinical program and study design. The setback has triggered multiple shareholder law firm investigations into potential securities law violations, raising fresh questions about Corcept’s regulatory communication, risk...

Earlier this week, COMPASS Pathways plc reported highly statistically significant and clinically meaningful positive Phase 3 results for its psilocybin-based therapy COMP360 in treatment-resistant depression, alongside generally well-tolerated safety data and a request for an FDA meeting on a potential rolling submission. The company paired this clinical milestone with a US$150,000,000 follow-on equity offering, underlining how pivotal COMP360 has become to its future plans. We’ll now look...

Agnico Eagle Mines (NYSE:AEM) has acquired shares in Maple Gold Mines as part of a recent deal. The company has also outlined an extensive exploration program scheduled to run through 2026. The program targets several core assets, with a focus on mine life, mineral reserves, and key pipeline projects. Agnico Eagle Mines, a major gold producer, is using its new position in Maple Gold Mines to widen its exposure to prospective projects while it works its existing portfolio harder. The 2026...

In February 2026, Halozyme Therapeutics reported Q4 and full-year 2025 results showing revenue rising to US$451.77 million for the quarter and US$1.40 billion for the year, but a quarterly net loss of US$141.59 million driven in part by a US$48.70 million intangible asset impairment. Despite the earnings miss linked to acquisition-related costs and write-downs, Halozyme reaffirmed 2026 revenue guidance of US$1.71 billion to US$1.81 billion, underscoring management’s confidence in its...

Promethos Capital has fully exited its position in Sprouts Farmers Market (NasdaqGS:SFM). The divestment removes one institutional shareholder at a time when the company is planning aggressive store expansion. Sprouts Farmers Market continues to focus on differentiated product offerings despite this shift in institutional ownership. Sprouts Farmers Market, traded as NasdaqGS:SFM, operates in the natural and organic grocery space, focusing on fresh and specialty products. The exit by...

Bitmine Immersion Technologies (NYSEAM:BMNR) has invested US$200 million in Beast Industries, the content company founded by YouTube creator MrBeast. The deal creates a partnership aimed at using MrBeast’s large audience to support Bitmine’s fintech expansion and platform integration. For you as an investor, this move points to Bitmine looking beyond its core immersion technology roots and into creator led distribution. Tapping into Beast Industries gives NYSEAM:BMNR a direct line to a...

Chevron (NYSE:CVX) has agreed to enter four offshore exploration blocks in Greece through a consortium with HELLENiQ ENERGY. The Greek blocks focus on ultra deepwater hydrocarbon exploration and are awaiting parliamentary ratification. In parallel, Chevron has secured an onshore exploration block in Libya, expanding its access in North Africa. These new agreements extend Chevron’s upstream footprint across the Mediterranean and North African regions. For you as an investor, this move ties...

Wondering whether IAMGOLD’s current share price lines up with its underlying worth, or if the market has run ahead of itself? This article is going to break that question down in plain terms. The stock last closed at CA$28.40, after a 3.1% pullback over the past week. The 30 day and year to date returns of 18.6% and 27.7% sit alongside a 1 year gain of 214.2% and a 3 year performance of around 8x, which will naturally catch investors’ attention. Recent coverage of IAMGOLD has focused on its...

Hakuten (TSE:2173) FY 2025 Earnings Snapshot Hakuten (TSE:2173) closed out FY 2025 with fourth quarter revenue of ¥8,386 million and basic EPS of ¥54.29, capping a year in which trailing twelve month revenue reached ¥23,336 million and EPS came in at ¥122.56. The company has seen quarterly revenue move from ¥5,998 million in Q4 FY 2024 to ¥8,386 million in Q4 FY 2025, while basic EPS shifted from ¥27.30 to ¥54.29 over the same period, alongside trailing EPS rising from ¥56.44 to ¥122.56. With...

AST SpaceMobile unfolded its BlueBird 6 satellite, the largest commercial communications array in low Earth orbit. The deployment validates key pieces of its space based cellular broadband architecture and signal beaming to standard smartphones. This milestone is a core step toward commercial satellite to cellphone services for AST SpaceMobile, ticker NasdaqGS:ASTS. For investors watching NasdaqGS:ASTS, this technical success comes with a share price of $83.03 and a very large 3 year...

If you are wondering whether National HealthCare is still reasonably priced after a strong run, this article will walk through what the current share price could mean for long term investors. The stock last closed at US$164.96, with returns of 1.4% over 7 days, 20.3% over 30 days, 26.5% year to date, 65.4% over 1 year, 203.2% over 3 years and 184.2% over 5 years. Recent attention around National HealthCare has focused on its role as a long term care and senior living provider, along with...

If you are wondering whether Borregaard is fairly priced or offering value right now, this article will walk through what the current share price could imply. The stock last closed at NOK 176.20, with recent returns of 0.7% over 7 days, an 11.1% decline over 30 days, a 10.4% decline year to date, and a 9.3% decline over the past year, compared to gains of 5.2% over 3 years and 20.1% over 5 years. These mixed returns come as investors continue to weigh Borregaard's positioning in materials...

Why GameStop Is Back on Investors’ Radar GameStop (GME) has drawn fresh attention after recent share price swings, with the stock showing a mix of shorter term declines and gains over the month and past 3 months. Investors are reassessing what the current valuation implies. See our latest analysis for GameStop. At a share price of $23.26, GameStop’s recent swings include a 10.24% 30 day share price return and 13.91% 90 day share price return. The 1 year total shareholder return of a 12.74%...

Tesla has avoided a threatened suspension of its California vehicle sales license by agreeing to drop Autopilot marketing language, resolving a nearly three year dispute with the state DMV. The company is ending production of its Model S and Model X vehicles while accelerating plans around its Optimus humanoid robot, robotaxi concepts and the Cybercab project. These moves reflect a shift in Tesla’s priorities toward artificial intelligence, robotics and autonomous mobility platforms. Tesla...

T. Rowe Price Group recently reported fourth-quarter and full-year 2025 results showing higher revenue and earnings per share, completed a long-running share repurchase program dating back to 2003, and in February 2026 announced a higher quarterly dividend of US$1.30 per share payable on March 30, 2026. The dividend increase marks the firm’s 40th consecutive year of regular annual dividend growth since its IPO, underscoring a long history of returning cash to shareholders alongside ongoing...

Ormat Technologies (ORA) is back on investor radars after a recent daily move of about 5%. This has drawn attention to how its geothermal, solar, and energy storage mix fits into broader clean energy portfolios. See our latest analysis for Ormat Technologies. That 5.10% 1 day share price return sits within a broader positive pattern, with a 90 day share price return of 13.98% and a 1 year total shareholder return of 90.74%, hinting that sentiment around Ormat's clean energy and storage assets...

In February 2026, Copa Holdings’ board approved a 2026 quarterly dividend of US$1.71 per share, with payments scheduled for March, June, September, and December, alongside reporting fourth-quarter 2025 revenue of US$962.89 million and net income of US$172.62 million. The combination of higher dividends and year-on-year growth in full-year 2025 revenue and earnings per share highlights management’s confidence in the company’s financial position and cash-generation capacity. Next, we’ll...

If you are trying to figure out whether TG Therapeutics at around US$29 per share is offering good value or just noise, you are in the right place. The stock has had mixed returns, with a 0.3% decline over the last 7 days, a 4.9% decline over 30 days, a 0.8% decline year to date, a 6.7% decline over 1 year and a 78.6% gain over 3 years, while the 5 year return stands at a 35.0% decline. Recent attention on TG Therapeutics has centered on its product portfolio and regulatory milestones in the...

MaxLinear, Inc. recently fixed its Board size at eight directors and appointed Western Digital Executive Vice President and CFO Kris Sennesael as a Class I director and Audit Committee member, effective 13 February 2026, with his term running through the 2028 annual meeting. By adding a long-time semiconductor finance leader with deep capital markets and operational experience, MaxLinear is signaling a stronger focus on governance, financial discipline, and scaling its connectivity...